Arcus Biosciences, Inc. — Director's Dealing 2018

Mar 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-03-19

Reporting Person: KANEKO YASUNORI (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-19	Common Stock	C	505050	—	Acquired	505050	Indirect
2018-03-19	Common Stock	C	252524	—	Acquired	252524	Indirect
2018-03-19	Common Stock	C	33818	—	Acquired	96948	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-19	Series A Convertible Preferred Stock	$	C	505050	Disposed		Common Stock (505050)	Indirect
2018-03-19	Series B Convertible Preferred Stock	$	C	252524	Disposed		Common Stock (252524)	Indirect
2018-03-19	Series B Convertible Preferred Stock	$	C	31253	Disposed		Common Stock (31253)	Indirect
2018-03-19	Series C Convertible Preferred Stock	$	C	2565	Disposed		Common Stock (2565)	Indirect

Footnotes

F1: The total represents shares received upon conversion of shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock.

F2: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.Q